Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $110.62 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $64.21 | 1 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $46.41 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $46.41 | 2 | Takeda Pharmaceuticals U.S.A., Inc. ($46.41) |
| 2019 | $64.21 | 1 | Allergan Inc. ($64.21) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: ONCOLOGY | ||||||
| 07/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: ONCOLOGY | ||||||
| 08/21/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $64.21 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 105 | 125 | $14,690 | $3,258 |
| 2021 | 5 | 466 | 776 | $116,345 | $23,386 |
| 2020 | 2 | 81 | 106 | $16,040 | $3,346 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2022 | 71 | 82 | $7,380 | $1,906 | 25.8% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 34 | 43 | $7,310 | $1,352 | 18.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2021 | 165 | 324 | $55,080 | $10,727 | 19.5% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2021 | 167 | 178 | $19,660 | $4,293 | 21.8% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2021 | 30 | 158 | $19,750 | $4,051 | 20.5% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2021 | 86 | 91 | $14,105 | $2,811 | 19.9% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Facility | 2021 | 18 | 25 | $7,750 | $1,504 | 19.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2020 | 39 | 62 | $10,540 | $2,198 | 20.9% |
| 88112 | Cell examination of specimen | Facility | 2020 | 42 | 44 | $5,500 | $1,147 | 20.9% |
About Dr. Hui Liu, M.D
Dr. Hui Liu, M.D is a Anatomic Pathology healthcare provider based in East Meadow, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2008. The National Provider Identifier (NPI) number assigned to this provider is 1720240468.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hui Liu, M.D has received a total of $110.62 in payments from pharmaceutical and medical device companies, with $46.41 received in 2024. These payments were reported across 3 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($110.62).
As a Medicare-enrolled provider, Liu has provided services to 652 Medicare beneficiaries, totaling 1,007 services with total Medicare billing of $29,990. Data is available for 3 years (2020–2022), covering 9 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology
- Location East Meadow, NY
- Active Since 06/25/2008
- Last Updated 03/27/2020
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- NPI Number 1720240468
Products in Payments
- VRAYLAR (Drug) $64.21
- FRUZAQLA (Drug) $46.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.